Pay in 4 interest-free payments of $7.29 Learn more
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28
Research Insights Superior Weight Loss Outcomes In a 48-week phase 2 study, adults with obesity treated with retatrutide experienced mean weight reductions of 22.8% (8 mg dose) and 24.2% (12 mg dose), outperforming other weight loss medications
Your body absorbs whatever you take in
GLP-1RAs appear to exert dual therapeutic benefits by concurrently ameliorating neuronal and vascular pathologies through stabilization of the BRB and suppression of inflammation-driven angiogenesis
TRIUMPH-3 (NCT05882045): 80-week weight management trial in adults with obesity/overweight and established cardiovascular disease (N=1,949)
Youll Have to Manage Side Effects Nausea and vomiting were the main side effects that Pickford and Lynn-Pullman experienced in the early days of treatment
Regular check-ins with PlexusDx support your progress, address side effects, and adjust your plan as needed while your antidepressant regimen remains stable
.png)
